+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gastrointestinal Drugs Market Research Report by Drug Category, by Route of Administration, by Disease Type, by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5122730
  • Report
  • July 2020
  • Region: United States
  • 96 pages
  • 360iResearch™
UP TO OFF
until Mar 31st 2021

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca plc
  • Johnson & Johnson
The United States Gastrointestinal Drugs Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Gastrointestinal Drugs Market.

Market Segmentation & Coverage:

This research report categorizes the Gastrointestinal Drugs market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug Category, the Gastrointestinal Drugs Market studied across Acid Neutralizers, Anti-Inflammatory, Antiemetic and Antinauseants, Biologics, and Laxatives and Anti-diarrheal.

Based on Route of Administration, the Gastrointestinal Drugs Market studied across Oral, Parenteral, and Rectal.

Based on Disease Type, the Gastrointestinal Drugs Market studied across Gastroesophageal Reflux Disorder and Irritable Bowel Syndrome.

Based on End User, the Gastrointestinal Drugs Market studied across Hospital Pharmacies and Retail Pharmacies.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the United States Gastrointestinal Drugs Market including Abbott Laboratories, AbbVie Inc., AstraZeneca plc, Bausch Health Companies Inc., and Johnson & Johnson.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Gastrointestinal Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Gastrointestinal Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Gastrointestinal Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Gastrointestinal Drugs Market?
4. What is the competitive strategic window for opportunities in the United States Gastrointestinal Drugs Market?
5. What are the technology trends and regulatory frameworks in the United States Gastrointestinal Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the United States Gastrointestinal Drugs Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca plc
  • Johnson & Johnson
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Market Outlook
3.2. Drug Category Outlook
3.3. Route of Administration Outlook
3.4. Disease Type Outlook
3.5. End User Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. United States Gastrointestinal Drugs Market, By Drug Category
6.1. Introduction
6.2. Acid Neutralizers
6.3. Anti-Inflammatory
6.4. Antiemetic and Antinauseants
6.5. Biologics
6.6. Laxatives and Anti-diarrheal

7. United States Gastrointestinal Drugs Market, By Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral
7.4. Rectal

8. United States Gastrointestinal Drugs Market, By Disease Type
8.1. Introduction
8.2. Gastroesophageal Reflux Disorder
8.3. Irritable Bowel Syndrome

9. United States Gastrointestinal Drugs Market, By End User
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Retail Pharmacies

10. Competitive Strategic Window
10.1. Introduction
10.2. Competitive Strategic Window, by Drug Category
10.3. Competitive Strategic Window, by Route of Administration
10.4. Competitive Strategic Window, by Disease Type
10.5. Competitive Strategic Window, by End User

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. AbbVie Inc.
12.3. AstraZeneca plc
12.4. Bausch Health Companies Inc.
12.5. Johnson & Johnson

13. Appendix
13.1. Discussion Guide
13.2. Edition Details
13.3. License Details
13.4. Pricing Details

LIST OF FIGURES
FIGURE 1. UNITED STATES GASTROINTESTINAL DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES GASTROINTESTINAL DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019 VS 2025 (USD MILLION)
FIGURE 6. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2019 VS 2025 (USD MILLION)
FIGURE 7. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
FIGURE 8. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES GASTROINTESTINAL DRUGS MARKET, BY TYPE
FIGURE 9. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 10. UNITED STATES GASTROINTESTINAL DRUGS MARKET: MARKET DYNAMICS
FIGURE 11. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2019 VS 2025 (USD MILLION)
FIGURE 12. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019 VS 2025 (USD MILLION)
FIGURE 13. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2019 VS 2025 (USD MILLION)
FIGURE 14. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DRUG CATEGORY, 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY DISEASE TYPE, 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY END USER, 2025 (USD MILLION)
FIGURE 19. UNITED STATES GASTROINTESTINAL DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 20. UNITED STATES GASTROINTESTINAL DRUGS MARKET: MARKET SHARE ANALYSIS

LIST OF TABLES
TABLE 1. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY ACID NEUTRALIZERS, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY ANTIEMETIC AND ANTINAUSEANTS, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY BIOLOGICS, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY LAXATIVES AND ANTI-DIARRHEAL, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY ORAL, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY PARENTERAL, 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY RECTAL, 2017-2025 (USD MILLION)
TABLE 10. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISORDER, 2017-2025 (USD MILLION)
TABLE 11. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, 2017-2025 (USD MILLION)
TABLE 12. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2017-2025 (USD MILLION)
TABLE 13. UNITED STATES GASTROINTESTINAL DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2017-2025 (USD MILLION)
TABLE 14. UNITED STATES GASTROINTESTINAL DRUGS MARKET: SCORES
TABLE 15. UNITED STATES GASTROINTESTINAL DRUGS MARKET: BUSINESS STRATEGY
TABLE 16. UNITED STATES GASTROINTESTINAL DRUGS MARKET: PRODUCT SATISFACTION
TABLE 17. UNITED STATES GASTROINTESTINAL DRUGS MARKET: RANKING
TABLE 18. UNITED STATES GASTROINTESTINAL DRUGS MARKET: MERGER & ACQUISITION
TABLE 19. UNITED STATES GASTROINTESTINAL DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 20. UNITED STATES GASTROINTESTINAL DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 21. UNITED STATES GASTROINTESTINAL DRUGS MARKET: INVESTMENT & FUNDING
TABLE 22. UNITED STATES GASTROINTESTINAL DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 23. UNITED STATES GASTROINTESTINAL DRUGS MARKET: EDITION DETAILS
TABLE 24. UNITED STATES GASTROINTESTINAL DRUGS MARKET: LICENSE DETAILS
TABLE 25. UNITED STATES GASTROINTESTINAL DRUGS MARKET: PRICING DETAILS
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca plc
  • Bausch Health Companies Inc.
  • Johnson & Johnson
Note: Product cover images may vary from those shown
Adroll
adroll